WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Jad Mills
Partner
Litigation
Seattle
jmills@wsgr.com

D206-883-2554

Download vCard
Open PDF

Jad A. Mills is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office under the America Invents Act and related federal court proceedings.

Jad has experience in matters before various federal district courts, the Patent Trial and Appeal Board, the International Trade Commission, the U.S. Court of Appeals for the Federal Circuit, California Superior Courts, and the California Court of Appeals.  He has experience in a wide variety of technology areas, including life sciences, pharmaceuticals, peptide chemistry, gene sequencing, diagnostics, medical devices, and electronic systems.

Jad has provided pro bono legal assistance throughout his career, including successfully representing multiple clients before the Court of Appeals for Veteran’s Claims.

Experience

Jad A. Mills is a partner in the Seattle office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on proceedings before the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office under the America Invents Act and related federal court proceedings.

Jad has experience in matters before various federal district courts, the Patent Trial and Appeal Board, the International Trade Commission, the U.S. Court of Appeals for the Federal Circuit, California Superior Courts, and the California Court of Appeals.  He has experience in a wide variety of technology areas, including life sciences, pharmaceuticals, peptide chemistry, gene sequencing, diagnostics, medical devices, and electronic systems.

Jad has provided pro bono legal assistance throughout his career, including successfully representing multiple clients before the Court of Appeals for Veteran’s Claims.

Education
  • J.D., Harvard Law SchoolCum Laude
  • B.S., Biochemistry, Brigham Young UniversityUniversity Honors
Associations and Memberships
  • PTAB Bar Association
    • Board of Directors, 2026-present
    • Vice Chair, Conference Committee, 2024-2026 

 

Admissions
  • State Bar of California
  • State Bar of Washington
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Northern District of California
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Supreme Court
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., Harvard Law SchoolCum Laude
  • B.S., Biochemistry, Brigham Young UniversityUniversity Honors
Associations and Memberships
  • PTAB Bar Association
    • Board of Directors, 2026-present
    • Vice Chair, Conference Committee, 2024-2026 

 

Admissions
  • State Bar of California
  • State Bar of Washington
  • U.S. District Court for the Central District of California
  • U.S. District Court for the Northern District of California
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Supreme Court
  • U.S. Patent and Trademark Office

Select Matters

  • Forte Biosciences Inc.* v. Univ. of Massachusetts (AIA Review)
  • Mylan* v. Bausch Health (AIA Reviews, CAFC Appeal)
  • Univ. of Washington v. Guardant Health* (AIA Reviews)
  • Route 92 Medical v. Q’Apel Medical* (D. Del.)
  • Gene Co.* v. Trustees of Columbia University (AIA Reviews)
  • Eyenovia, Inc. v. Sydnexis, Inc.* (AIA Reviews)
  • Empower Clinic Services L.L.C.* v. Eli Lilly & Co. (AIA Review)
  • Azurity Pharmaceuticals, Inc.* v. Helsinn Healthcare S.A. (AIA Reviews)
  • Neurocrine Biosciences, Inc. v. Spruce Biosciences, Inc.* (AIA Review)
  • ModernaTX, Inc. v. Arbutus Biopharma Corp.* (CAFC Appeals)
  • Kiosoft Techs., LLC. v. PayRange Inc.* (AIA Reviews)
  • Progenity, Inc.* v. Natera Inc. (AIA Reviews)
  • Alphatec Holdings, Inc. v. NuVasive, Inc.* (AIA Reviews, CAFC Appeals)
  • Mylan* v. St. Regis Mohawk Tribe (AIA Reviews, CAFC Appeal)
  • Luitpold v. Apicore* (AIA Review)
  • NanoCellect Biomedical, Inc.* v. Cytonome/St, LLC (AIA Reviews)
  • Mylan* v. Icos (AIA Review)
  • NuVasive, Inc.* v. Acantha (AIA Review)
  • Mylan* v. Monosol (AIA Review)
  • In re Matter of: Certain Footwear Products, ITC No. 337-TA-936 (Skechers*)
  • Mylan* v. Sanofi-Aventis (AIA Reviews, CAFC Appeals)
  • Apotex Inc*. v. Novartis AG (AIA Review)
  • Powertech Tech. Inc. v. Tessera, Inc.* (N.D. Cal.)
  • Mylan* v. Sanofi-Aventis (AIA Reviews, CAFC Appeals)
  • Razer USA LLC* v. Vizio, Inc. (C.D. Cal.)

*Party Represented

Matters

Select Matters

  • Forte Biosciences Inc.* v. Univ. of Massachusetts (AIA Review)
  • Mylan* v. Bausch Health (AIA Reviews, CAFC Appeal)
  • Univ. of Washington v. Guardant Health* (AIA Reviews)
  • Route 92 Medical v. Q’Apel Medical* (D. Del.)
  • Gene Co.* v. Trustees of Columbia University (AIA Reviews)
  • Eyenovia, Inc. v. Sydnexis, Inc.* (AIA Reviews)
  • Empower Clinic Services L.L.C.* v. Eli Lilly & Co. (AIA Review)
  • Azurity Pharmaceuticals, Inc.* v. Helsinn Healthcare S.A. (AIA Reviews)
  • Neurocrine Biosciences, Inc. v. Spruce Biosciences, Inc.* (AIA Review)
  • ModernaTX, Inc. v. Arbutus Biopharma Corp.* (CAFC Appeals)
  • Kiosoft Techs., LLC. v. PayRange Inc.* (AIA Reviews)
  • Progenity, Inc.* v. Natera Inc. (AIA Reviews)
  • Alphatec Holdings, Inc. v. NuVasive, Inc.* (AIA Reviews, CAFC Appeals)
  • Mylan* v. St. Regis Mohawk Tribe (AIA Reviews, CAFC Appeal)
  • Luitpold v. Apicore* (AIA Review)
  • NanoCellect Biomedical, Inc.* v. Cytonome/St, LLC (AIA Reviews)
  • Mylan* v. Icos (AIA Review)
  • NuVasive, Inc.* v. Acantha (AIA Review)
  • Mylan* v. Monosol (AIA Review)
  • In re Matter of: Certain Footwear Products, ITC No. 337-TA-936 (Skechers*)
  • Mylan* v. Sanofi-Aventis (AIA Reviews, CAFC Appeals)
  • Apotex Inc*. v. Novartis AG (AIA Review)
  • Powertech Tech. Inc. v. Tessera, Inc.* (N.D. Cal.)
  • Mylan* v. Sanofi-Aventis (AIA Reviews, CAFC Appeals)
  • Razer USA LLC* v. Vizio, Inc. (C.D. Cal.)

*Party Represented

Insights

    • Moderator, “What Is the State of Section 112 Law and Where Is It Headed?” 2023 PTAB Bar Association Annual Conference, Washington, D.C., March 2023
    • Co-author, "How 'Rocket Dockets' Are Affecting IPR Discretionary Denials," Law360, November 24, 2021
    • Patent Lab 601: PTAB Discretionary Denial, May 2021 CLE Presentation, Seattle, WA
    • Spring 2020 USPTO Trials Update, May 2020 CLE Presentation, Seattle, WA
    • Standing to Appeal from the PTAB, May 2019 CLE Presentation, Seattle, WA
    • Notable Developments in Post-Grant Review, 2018 CLE Presentation, Pittsburgh, PA
    • Patents, the PTAB, and Constitutional Law, 2018 Berkeley-Stanford Advanced Patent Law Institute, Palo Alto, CA
    • Editor and Contributor, The PTAB Review
      • April 2025
      • October 2024
      • August 2024
      • April 2024
      • September 2023
      • May 2023
      • October 2022
      • June 2022
      • March 2022
      • November 2021
      • July 2021
      • April 2021
      • October 2020
      • April 2020
      • October 2019
      • May 2019
      • April 2019
      • September 2018
      • June 2018
      • March 2018
    • Editor and Contributor, PTAB Year in Review
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
Insights

Insights

    • Moderator, “What Is the State of Section 112 Law and Where Is It Headed?” 2023 PTAB Bar Association Annual Conference, Washington, D.C., March 2023
    • Co-author, "How 'Rocket Dockets' Are Affecting IPR Discretionary Denials," Law360, November 24, 2021
    • Patent Lab 601: PTAB Discretionary Denial, May 2021 CLE Presentation, Seattle, WA
    • Spring 2020 USPTO Trials Update, May 2020 CLE Presentation, Seattle, WA
    • Standing to Appeal from the PTAB, May 2019 CLE Presentation, Seattle, WA
    • Notable Developments in Post-Grant Review, 2018 CLE Presentation, Pittsburgh, PA
    • Patents, the PTAB, and Constitutional Law, 2018 Berkeley-Stanford Advanced Patent Law Institute, Palo Alto, CA
    • Editor and Contributor, The PTAB Review
      • April 2025
      • October 2024
      • August 2024
      • April 2024
      • September 2023
      • May 2023
      • October 2022
      • June 2022
      • March 2022
      • November 2021
      • July 2021
      • April 2021
      • October 2020
      • April 2020
      • October 2019
      • May 2019
      • April 2019
      • September 2018
      • June 2018
      • March 2018
    • Editor and Contributor, PTAB Year in Review
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
Focus Areas
  • Intellectual Property
  • Life Sciences
  • Litigation
  • Patent Litigation
  • Post-Grant Review
  • Supreme Court and Appellate
Recent Insights
News Articles
Jad Mills, Richard Torczon Appointed to PTAB Bar Leadership
On March 20, 2026, Wilson Sonsini partner Jad Mills was elected to the board of directors of the PTAB Bar Association and senior counsel Richard Torczon was appointed to Chair of the organization’s Trials Committee. The PTAB Bar Association is committed to preserving and promoting the professional and ethical standards of lawyers and stakeholders who appear before the Patent Trial and Appeal Board (PTAB).
Learn More
News Articles
WIPR Recognizes Wilson Sonsini in USA Patent Rankings 2025
World Intellectual Property Review (WIPR) recognized Wilson Sonsini’s patents practice in the 2025 edition of “WIPR USA Patents,” a comprehensive analysis of the leading law firms and attorneys in the U.S. Wilson Sonsini is ranked as a “Recommended Firm” and is noted for its patent work and for its bench of deeply knowledgeable practitioners. The firm is also recognized for its work in cutting-edge technology sectors, including artificial intelligence and machine learning.
Learn More
View All
Recent Events
Affiliated Programs
2026 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2026 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
Learn More
Affiliated Programs
2025 PTAB Bar Association Annual Conference
Wilson Sonsini is proud to sponsor the 2025 PTAB Bar Association Annual Conference. This event will feature three days of engaging presentations and interactive discussions among practitioners, in-house counsel, and members of the bench, focusing on best practices, recent developments, and current policy considerations.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.